Guido Natoli

542 total citations
21 papers, 418 citations indexed

About

Guido Natoli is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Guido Natoli has authored 21 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Guido Natoli's work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). Guido Natoli is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). Guido Natoli collaborates with scholars based in Italy, Malaysia and United Kingdom. Guido Natoli's co-authors include E. Terzoli, Federica Cuppone, Cecilia Nisticò, Emilio Bria, Francesco Cognetti, Diana Giannarelli, Paolo Carlini, Mariangela Ciccarese, Michèle Milella and Lilia Calabrese and has published in prestigious journals such as Physical Review Letters, SHILAP Revista de lepidopterología and Journal of Molecular Biology.

In The Last Decade

Guido Natoli

20 papers receiving 403 citations

Peers

Guido Natoli
Nicole D. Facompre United States
Christine Sikora United States
Hui Han China
Kamil Wolyniec Australia
Asher D. Kelman United States
Guido Natoli
Citations per year, relative to Guido Natoli Guido Natoli (= 1×) peers Neeraj Rastogi

Countries citing papers authored by Guido Natoli

Since Specialization
Citations

This map shows the geographic impact of Guido Natoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Natoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Natoli more than expected).

Fields of papers citing papers by Guido Natoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Natoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Natoli. The network helps show where Guido Natoli may publish in the future.

Co-authorship network of co-authors of Guido Natoli

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Natoli. A scholar is included among the top collaborators of Guido Natoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Natoli. Guido Natoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Natoli, Guido, et al.. (2025). The role of bone radiotherapy during immune checkpoint inhibitors treatment of non-small-cell lung cancer: a single-institution experience. Therapeutic Advances in Medical Oncology. 17. 22777187–22777187. 1 indexed citations
2.
Angelucci, Francesco, Fulvio Saccoccia, Matteo Ardini, et al.. (2013). Switching between the Alternative Structures and Functions of a 2-Cys Peroxiredoxin, by Site-Directed Mutagenesis. Journal of Molecular Biology. 425(22). 4556–4568. 42 indexed citations
3.
Nelli, Fabrizio, Guido Natoli, Luca Moscetti, et al.. (2013). Epirubicin and docetaxel as first-line treatment for hormonal receptor positive metastatic breast cancer: the predictive value of luminal subtype: A retrospective cohort analysis. Journal of Chemotherapy. 25(2). 112–118. 1 indexed citations
4.
Merlano, Marco, Martino Monteverde, Ida Colantonio, et al.. (2012). Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer. Oral Oncology. 48(10). 1051–1057. 44 indexed citations
5.
Nelli, Fabrizio, Luca Moscetti, Guido Natoli, et al.. (2012). Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes. International Journal of Clinical Oncology. 18(2). 343–349. 9 indexed citations
6.
Vivenza, Daniela, Milena Gasco, Martino Monteverde, et al.. (2012). MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer. Oral Oncology. 48(7). 602–607. 9 indexed citations
7.
Natoli, Guido, et al.. (2012). Stage I non-small cell lung cancer: the presence of the lymphocyte-specific protein tyrosin kinase in the tumour infiltrate is associated with a better long-term prognosis. Interactive Cardiovascular and Thoracic Surgery. 15(1). 148–151. 5 indexed citations
8.
Denaro, Nerina, Cristiana Lo Nigro, Guido Natoli, et al.. (2011). The Role of p53 and MDM2 in Head and Neck Cancer. SHILAP Revista de lepidopterología. 2011. 1–8. 23 indexed citations
9.
Scarpino, Stefania, Enrico Duranti, Antonella Stoppacciaro, et al.. (2009). COX‐2 is induced by HGF stimulation in Met‐positive thyroid papillary carcinoma cells and is involved in tumour invasiveness. The Journal of Pathology. 218(4). 487–494. 20 indexed citations
10.
Belgrado, Jean-Paul, et al.. (2009). Intermittent pneumatic compression in the treatment of lymphedema: Current state of the knowledge. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 5 indexed citations
11.
Pace, Andrea, Cecilia Nisticò, Federica Cuppone, et al.. (2007). Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?. Clinical Breast Cancer. 7(7). 550–554. 35 indexed citations
12.
Natoli, Guido, et al.. (2007). Paclitaxel-induced nail changes: possible role of its vehicle (Cremophor EL).. PubMed. 16(6). 693–4. 1 indexed citations
13.
Belgrado, Jean-Paul, et al.. (2006). The skin temperature under multilayered bandages. Physical Review Letters. 16(47). 17–20. 1 indexed citations
14.
Bria, Emilio, Mariangela Ciccarese, Diana Giannarelli, et al.. (2006). Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: Pooled-analysis of 8794 patients. Cancer Treatment Reviews. 32(5). 325–332. 15 indexed citations
15.
Nisticò, Cecilia, Federica Cuppone, Emilio Bria, et al.. (2006). Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Anti-Cancer Drugs. 17(10). 1193–1200. 6 indexed citations
16.
Bria, Emilio, Cecilia Nisticò, Federica Cuppone, et al.. (2006). Benefit of taxanes as adjuvant chemotherapy for early breast cancer. Cancer. 106(11). 2337–2344. 106 indexed citations
17.
Destri, Giovanni Li, et al.. (1989). Cholecystectomy and colorectal cancer: an improbable correlation.. PubMed. 19(4). 355–9. 3 indexed citations
18.
O’Neill, Peter, Scott Davies, E.M. Fielden, et al.. (1988). The effects of pH and various salts upon the activity of a series of superoxide dismutases. Biochemical Journal. 251(1). 41–46. 65 indexed citations
19.
Genuardi, Maurizio, et al.. (1987). A girl with G syndrome and agenesis of the corpus callosum. American Journal of Medical Genetics. 28(2). 287–291. 17 indexed citations
20.
Galtieri, Antonio, Guido Natoli, Andrea Lania, & Lilia Calabrese. (1986). Isolation and characterization of Cu,Zn superoxide dismutase of the shark Prionace glauca. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 83(3). 555–559. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026